微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 5.93% | -8.35% | 19.8% | 10/69 | 4.85% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 4.95% | -9.17% | -25.45% | 8/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 6.64% | -38.63% | -24.63% | 28/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 8.81% | -22.04% | 36.17% | 19/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 6.47% | -16.62% | 18.72% | 17/69 | 0.66% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 5.45% | -5.71% | -49.63% | 8/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 10.82% | -0.28% | -4.25% | 20/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 11.3% | -1.05% | 45.62% | 15/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 7.76% | 2.37% | 34.26% | 14/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 5.78% | -4.15% | -46.73% | 12/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 10.85% | -9.28% | -4.99% | 24/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 11.42% | -5.15% | 50.66% | 12/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 7.58% | -16.79% | 25.7% | 12/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 6.03% | 2.2% | -49.58% | 3/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 11.96% | 14.89% | -0.66% | 18/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 12.04% | 23.23% | 32.16% | 11/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 9.11% | 40.37% | 54.41% | 7/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 5.9% | 22.41% | -43.32% | 6/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 10.41% | -12.81% | 6.55% | 24/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 9.77% | -18.04% | 50.54% | 20/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 6.49% | -32.4% | 34.65% | 13/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 4.82% | -21.37% | -59.63% | 5/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 11.94% | 13.93% | 0.17% | 21/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 11.92% | 12.45% | 24.17% | 8/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 9.6% | 25.65% | 56.61% | 4/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 6.13% | 35.92% | -41.51% | 4/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 10.48% | -1.5% | -1.13% | 30/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 10.6% | 32.67% | 38.74% | 17/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 7.64% | 21.46% | 69.4% | 13/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 4.51% | 71.48% | -57.61% | 8/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 10.64% | 17.44% | 33.17% | 31/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 7.99% | -9.62% | 27.03% | 35/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 6.29% | -19.97% | 139.16% | 25/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 2.63% | -42.2% | -70.97% | 31/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 9.06% | -34.4% | 2.49% | 38/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 8.84% | -25.78% | 12.47% | 27/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 7.86% | -17.18% | 72.75% | 15/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 4.55% | 1.79% | -67.05% | 8/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 13.81% | -8.42% | 15.95% | 29/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 11.91% | 1.28% | 25.5% | 17/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 9.49% | -0.42% | 112.3% | 10/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 4.47% | 0.9% | -70.36% | 11/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |